These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 34987523)

  • 1. Platelet CLEC2-Podoplanin Axis as a Promising Target for Oral Cancer Treatment.
    Hwang BO; Park SY; Cho ES; Zhang X; Lee SK; Ahn HJ; Chun KS; Chung WY; Song NY
    Front Immunol; 2021; 12():807600. PubMed ID: 34987523
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Podoplanin promotes cancer-associated thrombosis and contributes to the unfavorable overall survival in an ectopic xenograft mouse model of oral cancer.
    Lee HY; Yu NY; Lee SH; Tsai HJ; Wu CC; Cheng JC; Chen DP; Wang YR; Tseng CP
    Biomed J; 2020 Apr; 43(2):146-162. PubMed ID: 32441651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct Contact with Platelets Induces Podoplanin Expression and Invasion in Human Oral Squamous Cell Carcinoma Cells.
    Park SY; Lee SK; Lim M; Kim B; Hwang BO; Cho ES; Zhang X; Chun KS; Chung WY; Song NY
    Biomol Ther (Seoul); 2022 May; 30(3):284-290. PubMed ID: 35110423
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a novel platelet antagonist that binds to CLEC-2 and suppresses podoplanin-induced platelet aggregation and cancer metastasis.
    Chang YW; Hsieh PW; Chang YT; Lu MH; Huang TF; Chong KY; Liao HR; Cheng JC; Tseng CP
    Oncotarget; 2015 Dec; 6(40):42733-48. PubMed ID: 26528756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Functional characterization of recombinant snake venom rhodocytin: rhodocytin mutant blocks CLEC-2/podoplanin-dependent platelet aggregation and lung metastasis.
    Sasaki T; Shirai T; Tsukiji N; Otake S; Tamura S; Ichikawa J; Osada M; Satoh K; Ozaki Y; Suzuki-Inoue K
    J Thromb Haemost; 2018 May; 16(5):960-972. PubMed ID: 29488681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibody and lectin target podoplanin to inhibit oral squamous carcinoma cell migration and viability by distinct mechanisms.
    Ochoa-Alvarez JA; Krishnan H; Pastorino JG; Nevel E; Kephart D; Lee JJ; Retzbach EP; Shen Y; Fatahzadeh M; Baredes S; Kalyoussef E; Honma M; Adelson ME; Kaneko MK; Kato Y; Young MA; Deluca-Rapone L; Shienbaum AJ; Yin K; Jensen LD; Goldberg GS
    Oncotarget; 2015 Apr; 6(11):9045-60. PubMed ID: 25826087
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional invadopodia formation through stabilization of the PDPN transcript by IMP-3 and cancer-stromal crosstalk for PDPN expression.
    Hwang YS; Xianglan Z; Park KK; Chung WY
    Carcinogenesis; 2012 Nov; 33(11):2135-46. PubMed ID: 22859271
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
    Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
    Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Polysaccharide-containing fraction from Artemisia argyi inhibits tumor cell-induced platelet aggregation by blocking interaction of podoplanin with C-type lectin-like receptor 2.
    Tseng CP; Huang YL; Chang YW; Liao HR; Chen YL; Hsieh PW
    J Food Drug Anal; 2020 Jan; 28(1):115-123. PubMed ID: 31883599
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulin-like growth factor-II mRNA binding protein-3 and podoplanin expression are associated with bone invasion and prognosis in oral squamous cell carcinoma.
    Hwang YS; Ahn SY; Moon S; Zheng Z; Cha IH; Kim J; Zhang X
    Arch Oral Biol; 2016 Sep; 69():25-32. PubMed ID: 27232357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Maackia amurensis seed lectin (MASL) on oral squamous cell carcinoma (OSCC) gene expression and transcriptional signaling pathways.
    Hamilton KL; Sheehan SA; Retzbach EP; Timmerman CA; Gianneschi GB; Tempera PJ; Balachandran P; Goldberg GS
    J Cancer Res Clin Oncol; 2021 Feb; 147(2):445-457. PubMed ID: 33205348
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PDPN
    Li Y; Ma Z; Li W; Xu X; Shen P; Zhang SE; Cheng B; Xia J
    Cell Death Dis; 2023 Nov; 14(11):759. PubMed ID: 37993428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A critical role of platelet TGF-β release in podoplanin-mediated tumour invasion and metastasis.
    Takemoto A; Okitaka M; Takagi S; Takami M; Sato S; Nishio M; Okumura S; Fujita N
    Sci Rep; 2017 Feb; 7():42186. PubMed ID: 28176852
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Positive and negative regulation of podoplanin expression by TGF-β and histone deacetylase inhibitors in oral and pharyngeal squamous cell carcinoma cell lines.
    Ohta M; Abe A; Ohno F; Hasegawa Y; Tanaka H; Maseki S; Kondo E; Kurita K; Nakanishi H
    Oral Oncol; 2013 Jan; 49(1):20-6. PubMed ID: 22840788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The podoplanin-CLEC-2 interaction promotes platelet-mediated melanoma pulmonary metastasis.
    Sheng M; Sun R; Fu J; Lu G
    BMC Cancer; 2024 Apr; 24(1):399. PubMed ID: 38561690
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of Core-Fucose-Deficient Humanized and Chimeric Anti-Human Podoplanin Antibodies.
    Kaneko MK; Ohishi T; Nakamura T; Inoue H; Takei J; Sano M; Asano T; Sayama Y; Hosono H; Suzuki H; Kawada M; Kato Y
    Monoclon Antib Immunodiagn Immunother; 2020 Oct; 39(5):167-174. PubMed ID: 33085938
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Maackia amurensis seed lectin (MASL) and soluble human podoplanin (shPDPN) sequence analysis and effects on human oral squamous cell carcinoma (OSCC) cell migration and viability.
    Yin AC; Holdcraft CJ; Brace EJ; Hellmig TJ; Basu S; Parikh S; Jachimowska K; Kalyoussef E; Roden D; Baredes S; Capitle EM; Suster DI; Shienbaum AJ; Zhao C; Zheng H; Balcaen K; Devos S; Haustraete J; Fatahzadeh M; Goldberg GS
    Biochem Biophys Res Commun; 2024 May; 710():149881. PubMed ID: 38583233
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets and cancer-associated thrombosis: focusing on the platelet activation receptor CLEC-2 and podoplanin.
    Suzuki-Inoue K
    Blood; 2019 Nov; 134(22):1912-1918. PubMed ID: 31778548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An Acid-Responsive Iron-Based Nanocomposite for OSCC Treatment.
    Zhao X; Leng D; Wang H; Jin H; Wu Y; Qin Z; Wu D; Wei X
    J Dent Res; 2024 Jun; 103(6):612-621. PubMed ID: 38684484
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The snake venom rhodocytin from Calloselasma rhodostoma- a clinically important toxin and a useful experimental tool for studies of C-type lectin-like receptor 2 (CLEC-2).
    Bruserud Ø
    Toxins (Basel); 2013 Apr; 5(4):665-74. PubMed ID: 23594438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.